MIL 38/Gallium 67Alternative Names: MIL 38/Gallium 67; MILGa
Latest Information Update: 16 Feb 2017
At a glance
- Originator Minomic International
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies; Radiopharmaceutical diagnostics
- Mechanism of Action Single-photon emission-computed tomography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Bladder cancer; Pancreatic cancer; Prostate cancer